Saturday 17 October 2026
Export TFX’s income statement to Excel — free account
Teleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
In the quarter to June 2026, revenue grew 28.9%, EPS fell 17.3%, free cash flow grew 220.1% and total debt rose 47.7%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years.
130.43
2.21
+1.72%
Follow TFX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (28.87%) | (28.10%) | (24.47%) | (7.90%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
5 | 5 | 5 | 4 | |
| (14.57%) | (14.47%) | (12.90%) | (4.27%) | ||
ROIC |
0.51% | 0.73% | 1.37% | (4.07%) | |
Return on Tangible Assets |
(63.25%) | (62.71%) | (54.08%) | (17.14%) | |
Average Days of Receivables |
59.03 | 62.73 | 63.30 | 177.68 | |
Free Cash Flow per Share |
3.87 | 0.58 | 0.03 | (0.80) | |
Free Cash Flow |
168.40 | 25.73 | 1.45 | (35.38) | |
Capital Expenditures |
(76.14) | (89.89) | (95.24) | (90.61) | |
| Other line items | |||||
Cash ROIC |
2.80% | 0.43% | 0.02% | (0.52%) | |
Accounts Receivable Turnover |
5.13 | 5.12 | 6.96 | 2.29 | |
Accounts Payable Turnover |
6.75 | 6.66 | 7.65 | 3.30 | |
Inventory Turnover |
1.94 | 1.86 | 2.45 | 0.65 | |
Average Days of Payables |
51.48 | 54.95 | 54.50 | 128.87 | |
Days of Inventory on Hand |
126.44 | 145.72 | 169.28 | 623.31 | |
Tax Rate |
(0.61) | (1.04) | 1.38 | (0.10) | |
Research and Development Expense of Revenue |
8.10% | 7.71% | 7.27% | 8.29% | |
Selling, General and Administrative Expense of Revenue |
38.56% | 37.30% | 36.14% | 41.56% | |
Share Based Compensation of Revenue |
1.14% | 1.21% | 1.29% | 2.06% | |
Interest Coverage |
0.39 | 0.58 | 1.18 | (4.41) | |
Operating CF/Net income |
(0.24) | (0.11) | (0.11) | (0.17) | |
Depreciation/Fixed assets |
0.45 | 0.42 | 0.37 | 0.82 | |
Capex/Depreciation |
(0.36) | (0.45) | (0.52) | (0.16) | |
Revenue per Share |
51.75 | 48.05 | 44.66 | 27.52 | |
Operating CF per Share |
5.61 | 2.61 | 2.17 | 1.25 | |
Capex per Share |
(1.75) | (2.03) | (2.13) | (2.05) | |
Capex to Sales |
0.03 | 0.04 | 0.05 | 0.07 |
Columns are period end dates · fundamentals updated 1 Oct 2026